Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
IDI — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree IDI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

IDI — Performance
IDI insider buying image
The table below summarizes the most recent IDI insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why IDI insider buys are important for investors to follow.
DateInsiderPriceAmount
8-19-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.78
CAGR » 		$27,246.00
5,700 shares
6-28-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.32
CAGR » 		$10,800.00
2,500 shares
6-27-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.35
CAGR » 		$21,750.00
5,000 shares
6-20-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.54
CAGR » 		$18,160.00
4,000 shares
6-20-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.65
CAGR » 		$23,250.00
5,000 shares
6-7-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.70
CAGR » 		$14,100.00
3,000 shares
6-2-2016
Insider Buy		 Ryan Schulke
Director and >10% Owner		 $4.89
CAGR » 		$48,900.00
10,000 shares
6-1-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.80
CAGR » 		$16,800.00
3,500 shares
6-1-2016
Insider Buy		 Matthew Conlin
>10% Owner		 $4.86
CAGR » 		$24,300.00
5,000 shares
6-1-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.78
CAGR » 		$47,800.00
10,000 shares
5-24-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.84
CAGR » 		$16,940.00
3,500 shares
5-24-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.94
CAGR » 		$58,292.00
11,800 shares
5-18-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $5.25
CAGR » 		$2,202,532.50
419,530 shares
5-9-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.80
CAGR » 		$10,512,000.00
2,190,000 shares
5-9-2016
Insider Buy		 James Patrick Reilly
President		 $4.79
CAGR » 		$4,311.00
900 shares
2-18-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.70
CAGR » 		$9,400.00
2,000 shares
3-28-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.91
CAGR » 		$19,640.00
4,000 shares
3-22-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.98
CAGR » 		$99,600.00
20,000 shares
3-16-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.81
CAGR » 		$12,025.00
2,500 shares
3-2-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.97
CAGR » 		$19,890.00
4,000 shares
2-16-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.70
CAGR » 		$23,500.00
5,000 shares
2-16-2016
Insider Buy		 Matthew Conlin
 $5.05
CAGR » 		$100,982.00
20,000 shares
2-10-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.45
CAGR » 		$33,375.00
7,500 shares
1-28-2016
Insider Buy		 Ryan Schulke
Director		 $4.61
CAGR » 		$30,907.10
6,700 shares
1-27-2016
Insider Buy		 James Patrick Reilly
President		 $4.50
CAGR » 		$4,500.00
1,000 shares
1-27-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.55
CAGR » 		$22,767.00
5,000 shares
1-26-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.48
CAGR » 		$8,952.00
2,000 shares
1-26-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $4.36
CAGR » 		$21,803.00
5,000 shares
1-20-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.00
CAGR » 		$8,000.00
2,000 shares
1-19-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.49
CAGR » 		$26,940.00
6,000 shares
1-15-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $4.97
CAGR » 		$27,310.25
5,500 shares
1-12-2016
Insider Buy		 Matthew Conlin
 $5.85
CAGR » 		$116,934.00
20,000 shares
1-8-2016
Insider Buy		 Phillip Frost, M.D et. al.
Director and >10% Owner		 $5.98
CAGR » 		$119,654.00
20,000 shares
1-11-2016
Insider Buy		 Ryan Schulke
Director		 $5.81
CAGR » 		$116,236.00
20,000 shares
1-8-2016
Insider Buy		 Aaron Solomon
Interim CFO		 $6.06
CAGR » 		$1,515.00
250 shares
1-7-2016
Insider Buy		 Michael Brauser
Executive Chairman		 $6.31
CAGR » 		$31,572.50
5,000 shares
9-30-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $5.77
CAGR » 		$12,121.41
2,100 shares
9-29-2015
Insider Buy		 Jinbo Wang
Chief Accounting Officer		 $5.89
CAGR » 		$2,356.00
400 shares
9-25-2015
Insider Buy		 Aaron Solomon
Interim CFO		 $6.60
CAGR » 		$4,587.00
695 shares
9-4-2015
Insider Buy		 Michael Brauser
Executive Chairman		 $6.03
CAGR » 		$12,054.20
2,000 shares
8-27-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $6.32
CAGR » 		$31,617.00
5,000 shares
8-21-2015
Insider Buy		 Michael Brauser
Executive Chairman		 $6.28
CAGR » 		$31,392.00
5,000 shares
8-21-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $6.44
CAGR » 		$64,449.00
10,000 shares
8-19-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $7.10
CAGR » 		$35,499.00
5,000 shares
8-14-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $7.13
CAGR » 		$35,641.00
5,000 shares
8-13-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $7.91
CAGR » 		$39,538.00
5,000 shares
8-12-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $7.58
CAGR » 		$37,894.50
5,000 shares
8-11-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $7.66
CAGR » 		$38,296.50
5,000 shares
7-29-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $10.41
CAGR » 		$104,053.00
10,000 shares
7-27-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $8.96
CAGR » 		$44,815.50
5,000 shares
7-22-2015
Insider Buy		 Phillip Frost, M.D et. al.
>10% Owner		 $7.04
CAGR » 		$175,957.50
25,000 shares
7-22-2015
Insider Buy		 Aaron Solomon
Interim CFO		 $5.17
CAGR » 		$10,624.35
2,055 shares
7-21-2015
Insider Buy		 Michael Brauser
Executive Chairman		 $6.92
CAGR » 		$69,231.00
10,000 shares
7-21-2015
Insider Buy		 James Patrick Reilly
President		 $6.50
CAGR » 		$1,950.00
300 shares
7-21-2015
Insider Buy		 Derek Dubner
Co-Chief Executive Officer		 $7.44
CAGR » 		$37,200.00
5,000 shares

Also See: Institutional Holders of IDI
Also See: SEC filings

IDI Performance Since Insider Purchase
Below we present the annualized performance delivered by IDI stock since 8-19-2016 (the date of the most recent insider purchase). The performance of the investment from the time IDI insider buying occurred is the ultimate test of whether insiders were right about IDI being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 08/22/2016
End date: 09/23/2016
Start price/share: $4.94
End price/share: $5.02
Dividends collected/share: $0.00
Total return: 1.62%
Annualized Gain: 18.47%
Starting investment: $10,000.00
Ending investment: $10,162.00
Years: 0.09

IDI Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent IDI insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding IDI

IDI Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.